TRIAL DETAIL

Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery

Drug:
Trial Name:
Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery
NCT#:
Conditions:
Gastrointestinal Stromal Tumor
Status:
Recruiting
Phase:
2
Start Date 12/01/2016
Age of Trial (yrs) 2.8
Treatment Phase:
Gleevec-resistant
Drug Category:
PD-1 inhibitor + CTLA-4 inhibitor
Strategy:
Immunotherapy
Trial Type:
Specifically GIST and only GIST
Other Protocol IDs:
16-000525 NCI-2016-01004 16-000525 P30CA016042 US NIH Grant
Sponsor:
Johnson Comprehensive Cancer center
Patient Contact:
Arun Singh 310-829-5471 asingh@mednet.ucla.edu
Contact email:
Contact Phone:
Randomized:
Randomized
IV or Oral:
Subcutaneous
Trial Notes:
Collaborator: National Cancer Institute

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
10945 Le Conte Ave.
Los Angeles
CA
90095
USA